Skip to main content
. 2023 Oct 19;10:1215916. doi: 10.3389/fmed.2023.1215916

Figure 5.

Figure 5

During the treatment, the dynamic changes in kidney and liver markers: (A) creatinine, (B) urea, (C) alanine aminotransferase (ALT), (D) aspartate aminotransferase (AST), and (E) total bilirubin (TB), and (F) gamma-glutamyl transpeptidase (GGT) of the patients in the FNC group and patients in the placebo group. Data are median (SD). (Red line: FNC; blue line: placebo).